A study evaluating rate of infusion reactions in patients receiving casirivimab/imdevimab in the home setting
Latest Information Update: 03 Feb 2023
At a glance
- Drugs Casirivimab/imdevimab (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 03 Feb 2023 New trial record